James is Venture Partner at MedTech SuperConnector. He brings venture capital investment, corporate, and board experience from supporting venture-backed companies in the UK, Europe, and the US.

James was previously Investment Principal at Oxford Science Enterprises, where he focused on life sciences investing and served on the boards of university spinout portfolio companies. Before this, he was Head of Corporate Advisory at Mercia Asset Management and Investment Director at Fosun Pharma.

This built on his experience as Investment Manager at NBGI Ventures, where he focused on medical technology investing and served in board roles of portfolio companies in the UK, Europe, and the US.

James started his career at Cambridge Consultants and holds an MPhil in Computational Biology from the University of Cambridge, funded by the UK’s Engineering and Physical Sciences Research Council.